RecruitingPhase 3NCT05654922
Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant
Studying Transplant-related bronchiolitis obliterans
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Renovion, Inc.
- Principal Investigator
- Tim Whelan, MDMedical University of South Carolina
- Intervention
- ARINA-1(drug)
- Enrollment
- 100 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2023 – 2026
Study locations (20)
- Dignity Health - St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
- University of California Los Angeles School of Medicine, Los Angeles, California, United States
- University of California San Diego Health, San Diego, California, United States
- Advent Health, Orlando, Florida, United States
- University of South Florida, Tampa, Florida, United States
- Loyola University Medical Center, Maywood, Illinois, United States
- University of Iowa Hospital, Iowa City, Iowa, United States
- Johns Hopkins Hospital, Baltimore, Maryland, United States
- University of Minnesota Medical School, Minneapolis, Minnesota, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- Columbia University Irving Medical Center, New York, New York, United States
- Cleveland Clinic, Cleveland, Ohio, United States
- The Ohio State University Wexner Medical Center, Columbus, Ohio, United States
- Temple University Hospital, Philadelphia, Pennsylvania, United States
- Medical University of South Carolina, Charleston, South Carolina, United States
- +5 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05654922 on ClinicalTrials.govOther trials for Transplant-related bronchiolitis obliterans
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNANCT07018804Mechanisms and Targeted Therapy of Airway Basal Cell Dysfunction in Bronchiolitis Obliterans SyndromeHaikou Affiliated Hospital of Central South University Xiangya School of Medicine
- ACTIVE NOT RECRUITINGPHASE3NCT02181257Extracorporeal Photopheresis for Medicare Recipients of Lung AllograftsWashington University School of Medicine
See all trials for Transplant-related bronchiolitis obliterans →